View in EDS

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.

Saved in:
Bibliographic Details
Title: Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Authors: Fizazi, Karim1 (AUTHOR) karim.fizazi@gustaveroussy.fr, Tran, NamPhuong2 (AUTHOR), Fein, Luis3 (AUTHOR), Matsubara, Nobuaki4 (AUTHOR), Rodriguez-Antolin, Alfredo5 (AUTHOR), Alekseev, Boris Y6 (AUTHOR), Özgüroğlu, Mustafa7 (AUTHOR), Ye, Dingwei8 (AUTHOR), Feyerabend, Susan9 (AUTHOR), Protheroe, Andrew10 (AUTHOR), Sulur, Giri2 (AUTHOR), Luna, Yesenia2 (AUTHOR), Li, Susan11 (AUTHOR), Mundle, Suneel12 (AUTHOR), Chi, Kim N13 (AUTHOR)
Source: Lancet Oncology. May2019, Vol. 20 Issue 5, p686-700. 15p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 136156189
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fizazi%2C+Karim%22">Fizazi, Karim</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> karim.fizazi@gustaveroussy.fr</i><br /><searchLink fieldCode="AR" term="%22Tran%2C+NamPhuong%22">Tran, NamPhuong</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fein%2C+Luis%22">Fein, Luis</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matsubara%2C+Nobuaki%22">Matsubara, Nobuaki</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rodriguez-Antolin%2C+Alfredo%22">Rodriguez-Antolin, Alfredo</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alekseev%2C+Boris+Y%22">Alekseev, Boris Y</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Özgüroğlu%2C+Mustafa%22">Özgüroğlu, Mustafa</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ye%2C+Dingwei%22">Ye, Dingwei</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feyerabend%2C+Susan%22">Feyerabend, Susan</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Protheroe%2C+Andrew%22">Protheroe, Andrew</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sulur%2C+Giri%22">Sulur, Giri</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luna%2C+Yesenia%22">Luna, Yesenia</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Susan%22">Li, Susan</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mundle%2C+Suneel%22">Mundle, Suneel</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chi%2C+Kim+N%22">Chi, Kim N</searchLink><relatesTo>13</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. May2019, Vol. 20 Issue 5, p686-700. 15p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=136156189
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(19)30082-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 686
    Titles:
      – TitleFull: Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fizazi, Karim
      – PersonEntity:
          Name:
            NameFull: Tran, NamPhuong
      – PersonEntity:
          Name:
            NameFull: Fein, Luis
      – PersonEntity:
          Name:
            NameFull: Matsubara, Nobuaki
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Antolin, Alfredo
      – PersonEntity:
          Name:
            NameFull: Alekseev, Boris Y
      – PersonEntity:
          Name:
            NameFull: Özgüroğlu, Mustafa
      – PersonEntity:
          Name:
            NameFull: Ye, Dingwei
      – PersonEntity:
          Name:
            NameFull: Feyerabend, Susan
      – PersonEntity:
          Name:
            NameFull: Protheroe, Andrew
      – PersonEntity:
          Name:
            NameFull: Sulur, Giri
      – PersonEntity:
          Name:
            NameFull: Luna, Yesenia
      – PersonEntity:
          Name:
            NameFull: Li, Susan
      – PersonEntity:
          Name:
            NameFull: Mundle, Suneel
      – PersonEntity:
          Name:
            NameFull: Chi, Kim N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1